MarketBeat | Real-Time Financial News and Analysis

Open Main Menu Open Sidebar

ACADIA Pharmaceuticals Company Profile (NASDAQ:ACAD)

Consensus Ratings for ACADIA Pharmaceuticals (NASDAQ:ACAD) (?)
Ratings Breakdown: 9 Buy Rating(s)
Consensus Rating:Buy (Score: 3.00)
Consensus Price Target: $45.00 (7.94% upside)

Analysts' Ratings History for ACADIA Pharmaceuticals (NASDAQ:ACAD)
Show:
DateFirmActionRatingPrice TargetActions
7/2/2015HC WainrightReiterated RatingBuy$50.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/8/2015Needham & Company LLCSet Price TargetBuy$38.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/8/2015JPMorgan Chase & Co.Reiterated RatingBuy$40.00 -> $45.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/16/2015Leerink SwannInitiated CoverageOutperform$48.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/12/2015Piper JaffrayReiterated RatingOverweight$39.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/12/2015Jefferies GroupLower Price TargetBuy$50.00 -> $47.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/12/2015Needham & Company LLCLower Price TargetBuy$40.00 -> $38.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/10/2015HC WainrightReiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/27/2015Needham & Company LLCSet Price TargetBuy$40.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/27/2015JMP SecuritiesBoost Price TargetOutperform$31.00 -> $50.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/27/2015Needham & Company LLCReiterated RatingBuy$40.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/24/2015HC WainrightInitiated CoverageBuy$50.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/6/2015Roth CapitalReiterated RatingBuy$42.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
1/28/2015Jefferies GroupBoost Price TargetBuy$42.00 -> $50.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
12/22/2014Needham & Company LLCBoost Price TargetBuy$26.00 -> $40.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
11/21/2014Cowen and CompanyInitiated CoverageOutperform$46.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/15/2014Morgan JosephInitiated CoverageOverweightView Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/15/2014JPMorgan Chase & Co.Initiated CoverageOverweight$33.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/4/2014Jefferies GroupBoost Price Target$26.00 -> $38.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
10/7/2013Ned Davis ResearchInitiated CoverageNeutralView Rating Details  Tweet This Rating  Share This Rating on StockTwits
8/8/2013Roth CapitalBoost Price TargetBuy$20.00 -> $23.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
8/7/2013Ladenburg ThalmannBoost Price TargetBuy$15.00 -> $24.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
8/7/2013Needham & Company LLCBoost Price TargetBuy$16.00 -> $26.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
8/7/2013MLV & Co.DowngradeBuy -> Hold$18.00 -> $20.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 7/6/2013 forward)